Showing results (491-500 of 537) with videos related to

Sort By:
Pageof 54
JNCI Cancer Spectrum|April 24, 2026
Understanding randomized controlled trial generalizability through an embedded molecular diagnostics trialPatrick Lewicki, Arnav Srivastava, Ralph Jiang, et al.
ACS Pharmacology & Translational Science|September 19, 2025
P2Y14 Receptor Antagonists: Piperidine Bioisosteres and Mutagenesis-Supported Molecular ModelingAsmita Pramanik, Zhiwei Wen, Matteo Pavan, et al.
Clinical Genitourinary Cancer|June 12, 2026
Robust Meta-Analysis of a Clinical Cell-Cycle Risk (CCR) Score Demonstrates Broadly Applicable Metastasis and Disease-Specific Mortality Risk Stratification in Men With Localized Prostate CancerTodd M Morgan, Lauren H Lenz, Ivan Henriquez, et al.
Autophagy|May 27, 2024
Development and characterization of phospho-ubiquitin antibodies to monitor PINK1-PRKN signaling in cells and tissueJens O Watzlawik, Xu Hou, Tyrique Richardson, et al.
Biorxiv : the Preprint Server for Biology|January 31, 2024
Development and characterization of phospho-ubiquitin antibodies to monitor PINK1-PRKN signaling in cells and tissueJens O Watzlawik, Xu Hou, Tyrique Richardson, et al.
European Urology Oncology|May 26, 2023
Impact of Magnetic Resonance Imaging Targeting on Pathologic Upgrading and Downgrading at Prostatectomy: A Systematic Review and Meta-analysisIlon C Weinstein, Xian Wu, Alexander Hill, et al.
Nucleic Acids Research|January 10, 2003
TRANSFAC: transcriptional regulation, from patterns to profilesV Matys, E Fricke, R Geffers, et al.
Cancer Research|January 1, 2016
Therapeutic Targeting of Tumor-Derived R-Spondin Attenuates β-Catenin Signaling and Tumorigenesis in Multiple Cancer TypesCecile Chartier, Janak Raval, Fumiko Axelrod, et al.
Nature Chemistry|October 19, 2023
Stereocontrolled access to thioisosteres of nucleoside di- and triphosphatesHai-Jun Zhang, Michał Ociepa, Molhm Nassir, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 4, 2012
Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumorsAustin Gurney, Fumiko Axelrod, Christopher J Bond, et al.
Pageof 54